• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

edoxaban - Articles and news items

edoxaban

Servier Canada to market edoxaban in Canada

Industry news / 27 June 2016 / Victoria White, Digital Content Producer

Edoxaban is an oral anticoagulant that specifically inhibits factor Xa, which is an important factor in the coagulation system that leads to blood clotting…

clot-edoxaban

NICE recommends edoxaban for deep vein thrombosis

Industry news / 26 August 2015 / Victoria White

NICE has recommended once-daily edoxaban for the treatment and prevention of recurrent DVT and pulmonary embolism, saying the drug is cost-effective for the NHS…

edoxaban

Real world ETNA registries of new once-daily edoxaban start in Europe

Industry news / 24 August 2015 / Victoria White

ETNA registries have commenced in Europe to collect a robust set of information on how once-daily edoxaban is being used in real world settings…

edoxaban

Daiichi Sankyo’s edoxaban launched in the UK

Industry news / 10 July 2015 / Victoria White

Edoxaban, a new blood-thinning drug therapy to help prevent stroke in patients with non-valvular atrial fibrillation, has been launched in the UK…

Lixiana

Swissmedic approves Lixiana for the prevention of stroke and systemic embolism in non-valvular atrial fibrillation

Industry news / 15 April 2015 / Daiichi Sankyo

Swissmedic has granted approval of Lixiana for the prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation…

Daiichi Sankyo logo

U.S. FDA approves Daiichi Sankyo’s once-daily SAVAYSA™ (edoxaban) tablets for reduction of stroke risk

Industry news, News / 9 January 2015 / Daiichi Sankyo

U.S. FDA approves Daiichi Sankyo’s once-daily SAVAYSA™ (edoxaban) tablets for reduction of stroke risk in non-valvular atrial fibrillation and for the treatment of venous thromboembolism…

Daiichi Sankyo logo

Daiichi Sankyo launches new formulation of LIXIANA® 60 mg Tablets (edoxaban) in Japan

Industry news / 8 December 2014 / Daiichi Sankyo

Daiichi Sankyo Company, Limited announced that it has launched a new formulation of LIXIANA®60 mg Tablets…

Daiichi Sankyo logo

Once-daily edoxaban evaluated in two subgroup analyses of East Asian patients from the largest comparative phase 3 trials of a novel oral anticoagulant

Industry news / 24 March 2014 / Daiichi Sankyo

Daiichi Sankyo Company, Limited announced late-breaking data from two pre-specified subgroup analyses of East Asian patients with non-valvular atrial fibrillation or venous thromboembolism enrolled in two phase 3 edoxaban studies…

Daiichi Sankyo logo

Daiichi Sankyo submits SAVAYSA(TM) (edoxaban) tablets New Drug Application to the U.S. FDA

Industry news / 9 January 2014 / Daiichi Sankyo

Submission based on the two largest comparative phase 3 clinical trials of a novel oral anticoagulant in patients with non-valvular atrial fibrillation or symptomatic venous thromboembolism…

Daiichi Sankyo logo

Daiichi Sankyo submits edoxaban Marketing Authorisation Application to the EMA for once-daily use for stroke prevention in atrial fibrillation and for the treatment and prevention of recurrence of venous thromboembolism

Industry news / 8 January 2014 / Daiichi Sankyo

Daiichi Sankyo is seeking approval for edoxaban for the prevention of stroke and systemic embolic events in patients with non-valvular atrial fibrillation…

Daiichi Sankyo logo

Daiichi Sankyo submits supplemental New Drug Application in Japan for LIXIANA® (Edoxaban Tosilate Hydrate) for new indications

Industry news / 19 December 2013 / Daiichi Sankyo Company

Daiichi Sankyo is seeking approval in Japan for edoxaban in new indications for non-valvular atrial fibrillation (AF) and symptomatic venous thromboembolism…

Daiichi Sankyo logo

Phase 3 data show Daiichi Sankyo’s once-daily edoxaban lowered incidence of VTE recurrence and clinically relevant bleeding

Industry news, News / 10 December 2013 / Daiichi Sankyo Company

This analysis of VTE patients with cancer was presented at the 2013 American Society of Hematology Annual Meeting and Exposition…

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +